Stock exchange and press releases of BBS will be published on these pages. Releases are published in Finnish and in English.
Contact information for the media: info@bbs-artebone.fi from which you can also request additional media material
Archived releases can be found:
2018
2019
2020
2021
11.01.2021 BBS-Bioactive Bone Substitutes Plc: New Schedule Estimate for the CE Marking of Company’s ARTEBONE® Product
23.12.2020 BBS-Bioactive Bone Substitutes Plc: Correction to the release of BBS-Bioactive Bone Substitutes Plc published on 21.12.2020 at 16:30 CET
21.12.2020 BBS-Bioactive Bone Substitutes Plc: BBS-Bioactive Bone Substitutes' financial calendar and Annual General Meeting in 2021
08.12.2020 BBS-Bioactive Bone Substitutes Plc: The information published in the Company Announcement by BBS-Bioactive Bone Substitutes Plc. on 9 November 2020 at 8:45 has proved to be incorrect
09.11.2020 BBS-Bioactive Bone Substitutes Plc: The whole patent regarding the product ARTEBONE® has been accepted in the USA
31.08.2020 Correction to the regulatory release of BBS-Bioactive Bone Substitutes Plc published on 31.8.2020 at 12:15 CET
31.08.2020 BBS-Bioactive Bone Substitutes Plc Interim Report 1.1.-30.6.2020
27.08.2020 Changes in the BBS-Bioactive Bone Substitutes Plc’s Management Team and Board of Directors
17.08.2020 BBS-Bioactive Bone Substitutes Oyj’s decisions of the Annual General Meeting 2020
07.08.2020 BBS-Bioactive Bone Substitutes Plc: The CE marking application of the Company’s ARTEBONEⓇ Paste product is in progress